Key Highlights
- MilliporeSigma launches M-Trace® Software & Mobile App to digitize sterility testing.
- Automates data documentation, reducing deviation, false positives, and human error.
- Supports the “Lab of the Future” with enhanced data analytics and trend tracking.
- Available in North America and Western Europe, expanding globally by end of 2024.
Source: Business Wire
Notable Quote
- “Microbiological quality control labs are critical to ensuring the safety of sterile medicine. Here, the consequences of noncompliance can be very serious. Our job is to offer the solution that ensures drugs are safe and brought to market to the patients who need them the most — so data traceability is essential. Digital innovations like M-Trace® bring us one step closer to making the ‘Lab of the Future’ a reality.” – Jean-Charles Wirth, Head of Science & Lab Solutions for the Life Science Business at Merck KGaA, Darmstadt, Germany
SoHC's Take
The launch of M-Trace® by MilliporeSigma marks a significant advancement in sterility testing within microbiological quality control labs. By automating the documentation process, M-Trace® not only enhances safety but also minimizes the risks associated with human error and noncompliance. This innovation aligns with the broader trend of digital transformation in laboratories, supporting the vision of the “Lab of the Future.” As pharmaceutical companies continue to prioritize patient safety and product integrity, tools like M-Trace® will be crucial in ensuring compliance and efficiency in drug manufacturing and testing processes.
